Affiliation:
1. The First Hospital of Zhejiang University of Traditional Chinese Medicine
2. Zhejiang Provincial People's Hospital
Abstract
Abstract
Nucleoside diphosphate kinase 4 (NME4) is aberrantly expressed in several cancer types. However, the function of NME4 in colorectal cancer (CRC) remains to be elucidated. Bioinformatic analysis and clinical sample collection revealed that NME4 was highly expressed in CRC tissues and positively correlated with stage and tumor size. Knockdown of NME4 expression inhibited the proliferation and migration of CRC cells and promoted apoptosis. Moreover, NME4 inhibition in vivo markedly suppressed the size and weight of tumors. Then, cDNA microarray and Ingenuity Pathway Analysis (IPA) analysis were applied to identify SMAD2 and mTOR signaling pathways as downstream targets of NME4. And it was confirmed that SMAD2 was significantly reduced in CRC tissues and significantly correlated with AJCC staging and positive numbers. Furthermore, overexpression of NME4 resulted in a substantial increase in SMAD2 expression. NME4 overexpression promoted cell proliferation and migration, whereas knockdown of SMAD2 greatly reversed its effects. Together, these results suggested that NME4 may act as a novel tumor-promoting factor that promotes CRC progression by regulating SMAD2 and mTOR signaling pathways.
Publisher
Research Square Platform LLC
Reference29 articles.
1. Epidemiology, Molecular Mechanisms, and Clinical Trials: an Update on Research on the Association Between Red Meat Consumption and Colorectal Cancer[J];Kossenas K;Curr Nutr Rep,2021
2. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America[J];Li N;Cancer Lett,2021
3. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J];Xia C;Chin Med J (Engl),2022
4. Colorectal cancer and absolute risks[J];Lawrence BJ;Gut,2021
5. Colorectal Cancer: Preoperative Evaluation and Staging[J];Mahmoud NN;Surg Oncol Clin N Am,2022